Bristol-Myers Squibb (72) | Uncategorized (6)

Recent Contracts

Description of Bristol-Myers Squibb Company (Filed With SEC on February 10, 2021)
Bristol-Myers Squibb Company Benefit Equalization Plan Savings and Investment Program, effective as of January 1, 2012 and as amended and restated effective as of January 1, 2020 (Filed With SEC on February 10, 2021)
Description of Bristol-Myers Squibb Company's securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 24, 2020)
Letter Agreement between Bristol-Myers Squibb Company and Mr. David Elkins, dated as of May 30, 2019 (Filed With SEC on February 24, 2020)
Letter Agreement between Bristol-Myers Squibb Company and Dr. Thomas J. Lynch, Jr., dated as of June 4, 2019 (Filed With SEC on July 25, 2019)
Form of Contingent Value Rights Agreement, between Bristol-Myers Squibb Company and the Trustee (as defined therein) (Filed With SEC on January 4, 2019)